Discover 5 Top Oncolytic Virus Startups

Discover 5 Top Oncolytic Virus Startups

Curious about new technological advancements in the BioTech industry? Explore our analysis of 59 global oncolytic virus startups & scaleups and learn how their solutions impact your business!

Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the BioTech industry. This time, you get to discover 5 hand-picked oncolytic virus startups.

Out of 59, the Global Startup Heat Map highlights 5 Top Oncolytic Virus Startups

The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.

The Global Startup Heat Map below reveals the distribution of the 59 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 BioTech startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 54 oncolytic virus startups, get in touch.

Oncolytic-Virus-Startups-BioTech-Heat-Map-StartUs-Insights-noresize

Click to download

Interested in exploring all 59 oncolytic virus startups?

 

AdCure Bio engineers Oncolytic Adenoviruses

Founding Year: 2016
Location: Atlanta, US
Partner for: Adenoviral Therapy, Metastatic Tumor Therapy

AdCure Bio is a US-based startup that offers cancer viro-immunotherapies. The startup’s proprietary Artificial Vectors for Intravascular Delivery (AVID) platform engineers adenoviruses to reach and destroy cancer cells. On intravenous administration, the viruses also stimulate anti-tumor immunity in non-resectable and metastatic tumors. Moreover, it selects immunologically distinct virus variants for repeated rounds of therapy, further improving the efficacy of anticancer treatment.

Theolytics offers Ovarian Cancer Therapy

Founding Year: 2017
Location: Oxford, UK
Partner for: Ovarian Cancer Treatment, Phenotypic Screening

British startup Theolytics is advancing oncolytic viral therapies. The startup’s phenotypic screening platform identifies therapies with targeted lytic potency, virus-payload synergy, and other desired properties. The startup’s lead candidate is an adenovirus-based ovarian cancer therapy that selectively destroys ovarian cancer cells. It also targets cancer-associated fibroblasts (CAFs) and triggers anticancer immune responses.

Bionoxx leverages Oncolytic Vaccinia Viruses

Founding Year: 2016
Location: Seongnam, South Korea
Partner for: Solid Tumors, Vaccinia Development

South Korean startup Bionoxx develops immune-oncology treatments for cancer. The startup’s technology combines oncolytic vaccinia viruses that increase safety and maximize adaptive immunity. It features a universal tumor-targeting antigen (UTTA) that seeks out solid tumors as well as eliminates residual or recurring tumors. Bionoxx’s pipeline includes standalone viruses as well as a combination therapy for the treatment of solid tumors.

Adze Biotechnology delivers Oncolytic Immunotherapies

Founding Year: 2018
Location: Oak Park, US
Partner for: Viral Delivery, Immunotherapy

Adze Biotechnology is a US-based startup that provides oncolytic immunotherapies. The startup’s therapies stimulate both innate and immune responses to cancer. The immunotherapies have multiple mechanisms of action — the oncolytic activity of viral backbones, induction of immunogenic death, and delivery of therapeutic payloads. By circumventing antiviral immune responses with proprietary modification, the startup’s therapies offer improved potency against cancer cells.

Virica Biotech improves Viral Medicines

Founding Year: 2018
Location: Ottawa, Canada
Partner for: Viral Manufacturing, Gene Therapy

Virica Biotech is a Canadian startup that improves the efficacy of viral medicines. The startup’s proprietary small molecules, Viral Sensitizers (VSE), alter signaling pathways, thereby lowering the antiviral defense at the cellular level. This improves the productivity of all kinds of viruses and a 100-fold increase in their yield. The startup’s solution improves the efficacy of oncolytic viruses, as well as other viral medicines such as gene therapies or vaccines.

Discover more BioTech Startups

BioTech startups such as the examples highlighted in this report focus on oncoimmunology, cancer vaccines, and anticancer therapeutics. While all of these technologies play a major role in advancing the BioTech industry, they only represent the tip of the iceberg. To explore more BioTech technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free BioTech Innovation Report to save your time and improve strategic decision-making.

Get in touch





    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    Get in touch





      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
      Get your free BioTech Innovation Report
      We’ll deliver it straight to your inbox!






        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
        Get your Pharma Innovation Report!
        We’ll deliver it straight to your inbox!






          This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
          Looking to discover BioTech solutions that match your criteria?
          Looking to discover BioTech solutions that match your criteria?




            This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

            Related Articles

            Resources
            Get your BioTech Innovation Report!
            We’ll deliver it straight to your inbox!






              This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
              Get your Pharma Innovation Report!
              We’ll deliver it straight to your inbox!






                This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
                Get your Healthcare Innovation Report!
                We’ll deliver it straight to your inbox!






                  This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
                  Get a sneak peak into the future of Artificial Intelligence!
                  We'll contact you!






                    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
                    Subscribe to our Newsletter!



                      This field is required.

                      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.